» Articles » PMID: 10764341

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. This Official Statement of the American Thoracic Society Was Adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society...

Overview
Specialty Critical Care
Date 2000 Apr 14
PMID 10764341
Citations 425
Affiliations
Soon will be listed here.
Citing Articles

Clinical perspectives of isoniazid-induced liver injury.

Lei S, Gu R, Ma X Liver Res. 2025; 5(2):45-52.

PMID: 39959342 PMC: 11791842. DOI: 10.1016/j.livres.2021.02.001.


Immune correlates of protection as a game changer in tuberculosis vaccine development.

Wang J, Fan X, Hu Z NPJ Vaccines. 2024; 9(1):208.

PMID: 39478007 PMC: 11526030. DOI: 10.1038/s41541-024-01004-w.


The effect of corticosteroids in developing active pulmonary tuberculosis among patients with COVID-19.

Praphakornmano T, Torvorapanit P, Siranart N, Ohata P, Suwanpimolkul G PLoS One. 2024; 19(10):e0309392.

PMID: 39413068 PMC: 11482670. DOI: 10.1371/journal.pone.0309392.


Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea.

Jo K, Yoon Y, Kim H, Kim J, Kang Y Tuberc Respir Dis (Seoul). 2024; 88(1):56-68.

PMID: 39374926 PMC: 11704725. DOI: 10.4046/trd.2024.0122.


Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.

Sankar J, Chauhan A, Singh R, Mahajan D Front Pharmacol. 2024; 15:1441147.

PMID: 39364056 PMC: 11447295. DOI: 10.3389/fphar.2024.1441147.